reference/6715066

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6715066

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	e319
issn	2157-9024
issueIdentifier	4
pageRange	e319-e319
publicationName	Oncogenesis
startingPage	e319
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2de62851aee5825eefb200d2346ccd5
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_eb52720397ebed2912acf38835766102 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3f085b5f9acfacb725efee6462b9650c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fd1763e09a87ad4f9738ef7da60ba1a0
bibliographicCitation	Kumar S, Peng X, Daley J, Yang L, Shen J, Nguyen N, Bae G, Niu H, Peng Y, Hsieh HJ, Wang L, Rao C, Stephan CC, Sung P, Ira G, Peng G. Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells. Oncogenesis. 2017 Apr 17;6(4):e319. PMID: 28414320; PMCID: PMC5520492.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a652b46c1c82263f466ba397cd6b2e7c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_496cdfe511b22f27b19a6f2d64226272 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_249f4e866d16029ec7cda1a71fb65dde http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe0ef5b57a0f565329ef5174654865cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_289e6ed30e87d27dbcfb12fcf7cc8cef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9e74a87e20660f4528e2316ca5699c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16e3229c5176bd89a9c1fa6f00ad094a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a527d2aee5327b5895a31d96f6156355 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba9ad21a286a6880e4a05c7cce2f7505 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_059cbc3cfb220f7dbd775a1b0a2f4632 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b403467d64b3d55c885092b12572d743 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3216ace450717f46c49f87bde0930b8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ba8319265120d23735b10f50d97a7df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5afdf2c07991455eec0d0fe87e8a3d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8df8348ccc7e73db1c00fb368eb3e95e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19f5ae360895d9dc71a19d4df778f5a8
date	2017-04-17^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/oncsis.2017.15 https://pubmed.ncbi.nlm.nih.gov/28414320 https://pubmed.ncbi.nlm.nih.gov/PMC5520492
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40513 https://portal.issn.org/resource/ISSN/2157-9024
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8937 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_676425afc91f8c5b45e4c3ea367ce167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766

Showing number of triples: 1 to 44 of 44.